Wednesday, 18 November 2026European Markets

AB SCIENCE Stock Bullish Momentum With A 11.19% Jump Today

Automated market report from our archive (2020-2024), published before source-traceability. How we work

Loading stream...

(vianews) - the market ended the session with ab science (ab.pa) rising 11.19% to €4.87 on wednesday while cac 40 rose 0.52% to €7,328.53.

ab science's last close was €4.38, 58.09% below its 52-week high of €10.45.

about ab science

ab science s.a., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. its lead compound is the masitinib, a tyrosine kinase inhibitor that is in phase iii clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, alzheimer's, severe asthma, and mastocytosis diseases, as well as in phase ii clinical trial to treat covid-19. the company is also developing ab8939, a synthetic microtubule destabiliser for haematology indications. the company markets its masitinib under the masivet brand in europe. ab science s.a. was incorporated in 2001 and is headquartered in paris, france.

earnings per share

as for profitability, ab science has a trailing twelve months eps of €-0.28.

yearly top and bottom value

ab science's stock is valued at €4.87 at 22:31 est, way under its 52-week high of €10.45 and way above its 52-week low of €4.02.

more news about ab science (ab.pa).

Are you or your business in this article?

If something is wrong, out of context or missing, tell us. We correct errors with a dated note, and people named in an article can publish their response under it.

Correct, add context or respond →

Not a source? Spotted an error? Report an error

How this story was made

Spotted an error? Use “Correct this article” (bottom right), or select any sentence, to report it or respond to that point.

  1. Published before we listed source documents with each article.
  2. Published 14 Jun 2023
  3. No responses yet from the people or organisations in this story. Are you in this story? Respond on the record ›
  4. Part of the Via News record, fingerprinted daily so it cannot be quietly rewritten. What that means › · Report an error ›